Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Poewe

Showing results (201-210 of 258) with videos related to

Pageof 26
Sort By:
Journal of Neurology, Neurosurgery, and Psychiatry|March 18, 2003
The natural course of Sneddon syndrome: clinical and magnetic resonance imaging findings in a prospective six year observation studyS M Boesch, A L Plörer, A J Auer, et al.
Clinical Neuropharmacology|August 1, 1990
CQA 206-291: a novel dopamine agonist in the treatment of Parkinson's diseaseO Rascol, N Fabre, H Teräväinen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 1, 1996
Iodine-123-iodo-lisuride SPECT in Parkinson's diseaseM Cordes, J Hierholzer, L Schelosky, et al.
European Journal of Neurology|August 1, 2012
Success rate, efficacy, and safety/tolerability of overnight switching from immediate- to extended-release pramipexole in advanced Parkinson's diseaseA H V Schapira, P Barone, R A Hauser, et al.
European Journal of Neurology|April 28, 2012
Patient-reported convenience of once-daily versus three-times-daily dosing during long-term studies of pramipexole in early and advanced Parkinson's diseaseA H V Schapira, P Barone, R A Hauser, et al.
European Journal of Neurology|May 17, 2014
Long-term safety and sustained efficacy of extended-release pramipexole in early and advanced Parkinson's diseaseR A Hauser, A H V Schapira, P Barone, et al.
Clinical Neuropharmacology|June 9, 1998
The safety of ropinirole, a selective nonergoline dopamine agonist, in patients with Parkinson's diseaseA E Schrag, D J Brooks, E Brunt, et al.
Nuklearmedizin. Nuclear Medicine|August 1, 1995
[Brain SPECT with 123I-lisuride in patients with Parkinson's disease and controls]J Hierholzer, M Cordes, L Schelosky, et al.
Neurology|August 12, 2011
Extended-release pramipexole in early Parkinson disease: a 33-week randomized controlled trialW Poewe, O Rascol, P Barone, et al.
Neurology|August 12, 2011
Extended-release pramipexole in advanced Parkinson disease: a randomized controlled trialAnthony H V Schapira, P Barone, R A Hauser, et al.
Pageof 26

Showing results (201-210 of 258) with videos related to

Sort By:
Pageof 26
Journal of Neurology, Neurosurgery, and Psychiatry|March 18, 2003
The natural course of Sneddon syndrome: clinical and magnetic resonance imaging findings in a prospective six year observation studyS M Boesch, A L Plörer, A J Auer, et al.
Clinical Neuropharmacology|August 1, 1990
CQA 206-291: a novel dopamine agonist in the treatment of Parkinson's diseaseO Rascol, N Fabre, H Teräväinen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 1, 1996
Iodine-123-iodo-lisuride SPECT in Parkinson's diseaseM Cordes, J Hierholzer, L Schelosky, et al.
European Journal of Neurology|August 1, 2012
Success rate, efficacy, and safety/tolerability of overnight switching from immediate- to extended-release pramipexole in advanced Parkinson's diseaseA H V Schapira, P Barone, R A Hauser, et al.
European Journal of Neurology|April 28, 2012
Patient-reported convenience of once-daily versus three-times-daily dosing during long-term studies of pramipexole in early and advanced Parkinson's diseaseA H V Schapira, P Barone, R A Hauser, et al.
European Journal of Neurology|May 17, 2014
Long-term safety and sustained efficacy of extended-release pramipexole in early and advanced Parkinson's diseaseR A Hauser, A H V Schapira, P Barone, et al.
Clinical Neuropharmacology|June 9, 1998
The safety of ropinirole, a selective nonergoline dopamine agonist, in patients with Parkinson's diseaseA E Schrag, D J Brooks, E Brunt, et al.
Nuklearmedizin. Nuclear Medicine|August 1, 1995
[Brain SPECT with 123I-lisuride in patients with Parkinson's disease and controls]J Hierholzer, M Cordes, L Schelosky, et al.
Neurology|August 12, 2011
Extended-release pramipexole in early Parkinson disease: a 33-week randomized controlled trialW Poewe, O Rascol, P Barone, et al.
Neurology|August 12, 2011
Extended-release pramipexole in advanced Parkinson disease: a randomized controlled trialAnthony H V Schapira, P Barone, R A Hauser, et al.
Pageof 26